Arena Pharmaceuticals, Inc. Accumulated Other Comprehensive Income
Arena Pharmaceuticals, Inc. had Accumulated Other Comprehensive Income of -$280.00 thousand as of 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2022-02-23
- 2021-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$280.00K.
- 2021-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $122.00K.
- 2021-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $92.00K.
- 2021-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $204.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2021-12-31 | -$280.00K 10-K · filed 2022-02-23 |
| 2021-09-30 | $122.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $92.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $204.00K 10-Q · filed 2021-05-05 |
| 2020-12-31 | $700.00K 10-K · filed 2022-02-23 |
| 2020-09-30 | $1.55M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $2.65M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $125.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $1.30M 10-K · filed 2021-02-23 |
| 2019-09-30 | $1.44M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $1.31M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $502.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$155.00K 10-K · filed 2020-02-27 |
| 2018-09-30 | -$20.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$177.00K 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$241.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | -$1.22M 10-K · filed 2019-02-28 |
| 2017-09-30 | -$828.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | -$385.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | -$2.29M 10-Q · filed 2017-05-09 |
| 2016-12-31 | -$3.10M 10-K · filed 2018-03-14 |
| 2016-09-30 | $867.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $173.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $1.41M 10-Q · filed 2016-05-09 |
| 2015-12-31 | -$1.18M 10-K · filed 2017-03-15 |
| 2015-09-30 | $409.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $3.29M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $2.76M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $2.91M 10-K · filed 2016-02-29 |
| 2014-09-30 | $3.71M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $23.65M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $59.05M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $5.73M 10-K · filed 2015-03-02 |
| 2013-09-30 | $5.59M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $4.29M 10-Q · filed 2013-08-05 |
| 2013-03-31 | $3.90M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $5.49M 10-K · filed 2014-03-03 |
| 2012-09-30 | $4.78M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $4.20M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $6.43M 10-Q · filed 2012-05-02 |
| 2011-12-31 | $4.74M 10-K · filed 2013-03-01 |
| 2011-09-30 | $6.52M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $9.66M 10-Q · filed 2011-08-09 |
| 2010-12-31 | $4.97M 10-K · filed 2012-03-15 |